Hearing Solutions Audiologist Medicare: Medicare Enrolled Practice Location: 724 Front St, Louisville, CO 80027 Phone: 303-666-8149 Fax: 303-666-9149 |
Hearing Solutions, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 722 Front St, Louisville, CO 80027 Phone: 303-666-8149 Fax: 303-666-9149 |
Mrs. Christine M Gerhardt-jewell, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 722 Front St, Louisville, CO 80027 Phone: 303-666-8149 Fax: 303-666-9149 |
News Archive
Advanced imaging technologies that promise to improve the development of effective drugs to treat lung cancer are the focus of the current special issue of Optics Express, an open-access journal published by the Optical Society (OSA). Research featured in the special focus issue on Imaging in Diagnosis and Treatment of Lung Cancer outlines standardized approaches to measure and compare tumor size, as well as to validate the accuracy of such measurements under defined settings.
Mayo Clinic and the Translational Genomics Research Institute are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.
Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected by a health care worker, according to a small study by researchers at the Stanford University School of Medicine.
At the Smarter Industries Symposium today in Barcelona, IBM announced it has entered into an agreement with Central Norway Regional Health Authority to provide information technology to support all hospitals in Norway and improve coordination and reporting of health information, logistics and finance. The agreement is estimated at $120 million USD.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
› Verified 1 days ago